Holen Sie sich die Stockscreener-App
18.64
7.31%
1.27
Handel nachbörslich:
18.88
0.24
+1.29%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt NEO?
Forum
Prognose
Aktiensplit
Neogenomics Inc Aktie (NEO) Neueste Nachrichten
NeoGenomics (NASDAQ:NEO) Healthcare Innovation Gains Attention - Kalkine Media
NeoGenomics (NASDAQ:NEO) Reaches New 12-Month HighHere's Why - MarketBeat
Neogenomics stock hits 52-week high at 16.93 USD - Investing.com
Neogenomics stock hits 52-week high at 16.93 USD By Investing.com - Investing.com India
NeoGenomics, Inc. Revenue Breakdown – NASDAQ:NEO - TradingView
NeoGenomics (NEO) Advances 1.44% to $16.17 as Buyers Hold Above Key SupportPercent Above MA - vinanet.vn
NeoGenomics (NASDAQ:NEO) Enters A New Growth Spotlight - Kalkine Media
NeoGenomics, Inc. (NASDAQ:NEO) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
Neogenomics Stock Price Forecast. Should You Buy NEO? - StockInvest.us
NeoGenomics (NEO) stake tops 8% for First Light’s Mathew Arens - Stock Titan
NeoGenomics | SCHEDULE 13G/A: Others - Moomoo
California State Teachers Retirement System Raises Position in NeoGenomics, Inc. $NEO - MarketBeat
NeoGenomics, Inc. (NEO) Stock Forecasts - Yahoo Finance
NeoGenomics Senior VP & Chief Accounting Officer Gregory Aunan Sells 80% Of Holding - simplywall.st
GC To Depart Cancer Diagnostic Co. NeoGenomics - Law360
Renaissance Technologies LLC Acquires New Shares in NeoGenomics, Inc. $NEO - MarketBeat
Form 8K NeoGenomics Inc For: 11 August By Investing.com - Investing.com India
Technical Reactions to NEO Trends in Macro Strategies - Stock Traders Daily
NeoGenomics announces planned departure of General Counsel Alicia Olivo - Investing.com
NeoGenomics (NEO) Slips to $16.50 as Biotech Diagnostic Stocks Face Cautious TradingVWAP Deviation - Vinanet
NeoGenomics (NASDAQ:NEO) Sets New 1-Year HighShould You Buy? - MarketBeat
MFG Wealth Management Inc. Takes Position in NeoGenomics, Inc. $NEO - marketbeat.com
NeoGenomics, Inc. (NEO) Stock forecasts - Yahoo Finance Australia
Has NeoGenomics (NEO) Priced In Its Turnaround Following Q2 Profitability? - simplywall.st
NeoGenomics (NEO) Is Up 8.4% After Q2 Profit Return And Raised 2026 Outlook – Has The Bull Case Changed? - finance.yahoo.com
Neogenomics stock hits 52-week high at 16.46 USD By Investing.com - Investing.com UK
Neogenomics stock hits 52-week high at 16.46 USD - Investing.com
NEOUSD (NEOUSD) Stock News Today - TradingKey
NeoGenomics Appoints Carolyn Starrett to its Board of Directors - The National Law Review
NeoGenomics, Inc. $NEO Stock Position Raised by Sei Investments Co. - MarketBeat
Dimensional Fund Advisors LP Buys 225,588 Shares of NeoGenomics, Inc. $NEO - MarketBeat
NeoGenomics, Inc. Revenue Breakdown – BX:NG9 - TradingView
NeoGenomics Laboratories Number of Employees 2026 | Employee Count & Headcount Data - Revelio Labs
Neogenomics Insider Sold Shares Worth $321,400, According to a Recent SEC Filing - marketscreener.com
NeoGenomics (NEO) accounting chief sells 20,000 shares, keeps equity awards - Stock Titan
BlackRock, Inc. Expands NeoGenomics Inc (NEO) Stake with Strategic Share Acquisition - GuruFocus
NeoGenomics Shareholder Action Reminder - TMX Newsfile
NeoGenomics, Inc. $NEO Shares Sold by Glenmede Trust Co. NA - MarketBeat
NeoGenomics, Inc. (NEO) Hit a 52 Week High, Can the Run Continue? - Yahoo Finance
NeoGenomics (NASDAQ:NEO) Reaches New 1-Year HighHere's What Happened - MarketBeat
NEO (NEO) holder to sell 20,000 shares after restricted stock vests - Stock Titan
NEO5107997 Bond Profile — Key Metrics - TradingView
Segall Bryant & Hamill LLC Lowers Holdings in NeoGenomics, Inc. $NEO - MarketBeat
NeoGenomics (NEO) Following Q2 Profit And Raised Outlook, Is Fair Value Already Priced In? - Yahoo Finance
Is NeoGenomics Inc (NEO) a Bargain After 3.7% Drop? GF Value Says Undervalued - GuruFocus
Trading the Move, Not the Narrative: (NEO) Edition - Stock Traders Daily
Planned insider share sale for NEO (NASDAQ: NEO) under Rule 144 - Stock Titan
Update: NeoGenomics Shares Rise After Q2 Beat - Moomoo
A Quick Look at Today's Ratings for NeoGenomics(NEO.US), With a Forecast Between $19 to $19 - moomoo.com
Neogenomics stock hits 52-week high at 15.61 USD By Investing.com - Investing.com Nigeria
Needham Raises Price Target on NeoGenomics to $19 From $15, Keeps Buy Rating - marketscreener.com
Needham raises Neogenomics stock price target on strong Q2 results By Investing.com - Investing.com Nigeria
NeoGenomics Shares Rise After Q2 Beat - marketscreener.com
NeoGenomics appoints Carolyn Starrett to its Board of Directors - scanx.trade
NeoGenomics Q2 Earnings, Revenue Rise; Ups Guidance - marketscreener.com
(NEO) NeoGenomics Expects 2026 Revenue Range $802 Million-$806 Million, vs. FactSet Est of $800.4 Million - marketscreener.com
Earnings Flash (NEO) NeoGenomics Posts Q2 Adjusted EPS $0.05, vs. FactSet Est of $0.03 - marketscreener.com
NeoGenomics (NEO) Is Down 7.7% After DOJ Settlement On Legacy Agreements – Has The Bull Case Changed? - simplywall.st
NeoGenomics in focus: Earnings test new diagnostic momentum By Investing.com - Investing.com South Africa
NEOGENOMICS ($NEO) Releases Q2 2026 Earnings, Stock Rises - Quiver Quantitative
NeoGenomics pays $10 million to settle kickback allegations after self-disclosing below-market deals - Peoples Gazette Nigeria
0.24%
1.51%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):